TrialClinical pharmacokinetics2003

No influence of ethnic origin on the pharmacokinetics and pharmacodynamics of melagatran following oral administration of ximelagatran, a novel oral direct thrombin inhibitor, to healthy male volunteers.

Linda C Johansson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.